Therapeutic Note(s)

Prescribers should be informed and stay current with a drug's official indications in accordance with Health Canada's approved product monograph.

For the treatment of HIV/AIDS. The prescriber must be approved for the Facilitated Access to HIV/AIDS Drug Products mechanism. For use as pre-exposure prophylaxis (PrEP) of HIV-1 in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 infection in adults at high risk for infection, in accordance with Health Canada's approved product monograph. Approval for the Facilitated Access to HIV/AIDS Drug Products mechanism is not required.